Clinical Trial Update: A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the pharmacokinetics, safety and tolerability of a long-acting cabotegravir formulation administered with recombinant human hyaluro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Cabotegravir long-acting (cabotegravir)
• Recombinant human hyaluronidase PH20 (hyaluronidase PH20)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: RECRUITING